nodes	percent_of_prediction	percent_of_DWPC	metapath
Vismodegib—ORM1—saliva—attention deficit hyperactivity disorder	0.107	0.155	CbGeAlD
Vismodegib—SHH—forebrain—attention deficit hyperactivity disorder	0.0836	0.121	CbGeAlD
Vismodegib—SHH—midbrain—attention deficit hyperactivity disorder	0.0552	0.0798	CbGeAlD
Vismodegib—SHH—nervous system—attention deficit hyperactivity disorder	0.0454	0.0656	CbGeAlD
Vismodegib—SHH—central nervous system—attention deficit hyperactivity disorder	0.0437	0.0632	CbGeAlD
Vismodegib—SHH—cerebellum—attention deficit hyperactivity disorder	0.0427	0.0617	CbGeAlD
Vismodegib—SMO—midbrain—attention deficit hyperactivity disorder	0.0386	0.0558	CbGeAlD
Vismodegib—SHH—brain—attention deficit hyperactivity disorder	0.0347	0.0501	CbGeAlD
Vismodegib—SMO—nervous system—attention deficit hyperactivity disorder	0.0318	0.0459	CbGeAlD
Vismodegib—SMO—central nervous system—attention deficit hyperactivity disorder	0.0306	0.0442	CbGeAlD
Vismodegib—SMO—cerebellum—attention deficit hyperactivity disorder	0.0299	0.0432	CbGeAlD
Vismodegib—SHH—Dopaminergic Neurogenesis—SLC6A3—attention deficit hyperactivity disorder	0.0249	0.0809	CbGpPWpGaD
Vismodegib—SMO—brain—attention deficit hyperactivity disorder	0.0243	0.0351	CbGeAlD
Vismodegib—ORM1—nervous system—attention deficit hyperactivity disorder	0.0139	0.02	CbGeAlD
Vismodegib—ORM1—central nervous system—attention deficit hyperactivity disorder	0.0134	0.0193	CbGeAlD
Vismodegib—CYP2C9—cardiovascular system—attention deficit hyperactivity disorder	0.0118	0.0171	CbGeAlD
Vismodegib—SMO—GPCRs, Other—DRD3—attention deficit hyperactivity disorder	0.0106	0.0343	CbGpPWpGaD
Vismodegib—SMO—GPCRs, Other—DRD4—attention deficit hyperactivity disorder	0.0103	0.0333	CbGpPWpGaD
Vismodegib—ABCG2—midbrain—attention deficit hyperactivity disorder	0.0101	0.0146	CbGeAlD
Vismodegib—ALB—brain—attention deficit hyperactivity disorder	0.0093	0.0134	CbGeAlD
Vismodegib—SHH—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00881	0.0286	CbGpPWpGaD
Vismodegib—SMO—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00835	0.0271	CbGpPWpGaD
Vismodegib—ABCG2—cerebellum—attention deficit hyperactivity disorder	0.00782	0.0113	CbGeAlD
Vismodegib—ABCG2—Fluoropyrimidine Activity—DPYD—attention deficit hyperactivity disorder	0.00759	0.0246	CbGpPWpGaD
Vismodegib—ABCB1—forebrain—attention deficit hyperactivity disorder	0.00755	0.0109	CbGeAlD
Vismodegib—SMO—GPCRs, Other—HTR2A—attention deficit hyperactivity disorder	0.00669	0.0217	CbGpPWpGaD
Vismodegib—SHH—FOXA1 transcription factor network—EP300—attention deficit hyperactivity disorder	0.00669	0.0217	CbGpPWpGaD
Vismodegib—CYP2C8—brain—attention deficit hyperactivity disorder	0.00654	0.00944	CbGeAlD
Vismodegib—ABCB1—cardiovascular system—attention deficit hyperactivity disorder	0.00639	0.00923	CbGeAlD
Vismodegib—ABCG2—brain—attention deficit hyperactivity disorder	0.00636	0.00918	CbGeAlD
Vismodegib—SHH—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00591	0.0192	CbGpPWpGaD
Vismodegib—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.00579	0.00837	CbGeAlD
Vismodegib—SHH—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00579	0.0188	CbGpPWpGaD
Vismodegib—SHH—Validated transcriptional targets of TAp63 isoforms—EP300—attention deficit hyperactivity disorder	0.00568	0.0184	CbGpPWpGaD
Vismodegib—SMO—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.0056	0.0182	CbGpPWpGaD
Vismodegib—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.00558	0.00806	CbGeAlD
Vismodegib—SMO—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00549	0.0178	CbGpPWpGaD
Vismodegib—ABCB1—midbrain—attention deficit hyperactivity disorder	0.00499	0.00721	CbGeAlD
Vismodegib—SHH—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.00462	0.015	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00452	0.0147	CbGpPWpGaD
Vismodegib—SMO—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.00438	0.0142	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00429	0.0139	CbGpPWpGaD
Vismodegib—ABCB1—nervous system—attention deficit hyperactivity disorder	0.0041	0.00592	CbGeAlD
Vismodegib—SHH—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00401	0.013	CbGpPWpGaD
Vismodegib—ABCB1—central nervous system—attention deficit hyperactivity disorder	0.00395	0.0057	CbGeAlD
Vismodegib—ABCB1—cerebellum—attention deficit hyperactivity disorder	0.00386	0.00557	CbGeAlD
Vismodegib—SMO—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.0038	0.0124	CbGpPWpGaD
Vismodegib—SHH—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00351	0.0114	CbGpPWpGaD
Vismodegib—SMO—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00333	0.0108	CbGpPWpGaD
Vismodegib—SHH—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00326	0.0106	CbGpPWpGaD
Vismodegib—SHH—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00316	0.0103	CbGpPWpGaD
Vismodegib—ABCB1—brain—attention deficit hyperactivity disorder	0.00313	0.00453	CbGeAlD
Vismodegib—SHH—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.0031	0.0101	CbGpPWpGaD
Vismodegib—SMO—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00309	0.01	CbGpPWpGaD
Vismodegib—SHH—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00307	0.00996	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00303	0.00985	CbGpPWpGaD
Vismodegib—SMO—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00299	0.00972	CbGpPWpGaD
Vismodegib—SHH—Disease—STUB1—attention deficit hyperactivity disorder	0.00298	0.00967	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00297	0.00965	CbGpPWpGaD
Vismodegib—SMO—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00294	0.00956	CbGpPWpGaD
Vismodegib—SMO—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00291	0.00944	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00287	0.00934	CbGpPWpGaD
Vismodegib—SHH—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00286	0.00928	CbGpPWpGaD
Vismodegib—CYP2C19—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.00285	0.00925	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00282	0.00915	CbGpPWpGaD
Vismodegib—SMO—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00271	0.00879	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00267	0.00868	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00253	0.00822	CbGpPWpGaD
Vismodegib—CYP3A4—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.00253	0.00821	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00209	0.00677	CbGpPWpGaD
Vismodegib—SHH—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.00207	0.00671	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00206	0.00669	CbGpPWpGaD
Vismodegib—SHH—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.002	0.0065	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00198	0.00642	CbGpPWpGaD
Vismodegib—SMO—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.00196	0.00636	CbGpPWpGaD
Vismodegib—ABCG2—HIF-2-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.00196	0.00635	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00195	0.00634	CbGpPWpGaD
Vismodegib—SMO—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.0019	0.00616	CbGpPWpGaD
Vismodegib—ALB—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.00187	0.00607	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.0018	0.00585	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00179	0.00582	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00176	0.0057	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00172	0.00559	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00171	0.00554	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.0017	0.00552	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00167	0.00544	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00166	0.0054	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00163	0.0053	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00162	0.00526	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00159	0.00517	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00159	0.00515	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00157	0.00511	CbGpPWpGaD
Vismodegib—ABCG2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00154	0.005	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00154	0.00499	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00151	0.00491	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—ADRA2C—attention deficit hyperactivity disorder	0.00151	0.00489	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00149	0.00484	CbGpPWpGaD
Vismodegib—ABCG2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00147	0.00477	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00147	0.00476	CbGpPWpGaD
Vismodegib—CYP2C8—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00145	0.0047	CbGpPWpGaD
Vismodegib—SHH—Disease—SNAP25—attention deficit hyperactivity disorder	0.00141	0.00459	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00139	0.00451	CbGpPWpGaD
Vismodegib—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00129	0.00419	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00122	0.00395	CbGpPWpGaD
Vismodegib—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00118	0.00382	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00115	0.00375	CbGpPWpGaD
Vismodegib—ABCG2—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.00115	0.00374	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.00106	0.00345	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.00103	0.00333	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.00101	0.00327	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000989	0.00321	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000973	0.00316	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000957	0.00311	CbGpPWpGaD
Vismodegib—ALB—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000949	0.00308	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000941	0.00306	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000937	0.00304	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000929	0.00302	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000908	0.00295	CbGpPWpGaD
Vismodegib—ALB—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000906	0.00294	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000892	0.0029	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000881	0.00286	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000866	0.00281	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000832	0.0027	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000821	0.00267	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000794	0.00258	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—ADRA2A—attention deficit hyperactivity disorder	0.000791	0.00257	CbGpPWpGaD
Vismodegib—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000776	0.00252	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—ADRA2C—attention deficit hyperactivity disorder	0.000776	0.00252	CbGpPWpGaD
Vismodegib—CYP2C8—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000774	0.00251	CbGpPWpGaD
Vismodegib—CYP2C8—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000768	0.0025	CbGpPWpGaD
Vismodegib—CYP2C8—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000763	0.00248	CbGpPWpGaD
Vismodegib—CYP2C19—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000691	0.00224	CbGpPWpGaD
Vismodegib—CYP2C19—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000686	0.00223	CbGpPWpGaD
Vismodegib—CYP2C19—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000681	0.00221	CbGpPWpGaD
Vismodegib—ALB—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00065	0.00211	CbGpPWpGaD
Vismodegib—CYP2C9—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00063	0.00205	CbGpPWpGaD
Vismodegib—CYP2C9—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000625	0.00203	CbGpPWpGaD
Vismodegib—ABCB1—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.000622	0.00202	CbGpPWpGaD
Vismodegib—CYP2C9—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000621	0.00202	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000606	0.00197	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.000594	0.00193	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000575	0.00187	CbGpPWpGaD
Vismodegib—ABCG2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000535	0.00174	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00051	0.00166	CbGpPWpGaD
Vismodegib—SHH—Disease—EP300—attention deficit hyperactivity disorder	0.000459	0.00149	CbGpPWpGaD
Vismodegib—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000415	0.00135	CbGpPWpGaD
Vismodegib—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000412	0.00134	CbGpPWpGaD
Vismodegib—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00041	0.00133	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	0.000408	0.00132	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000352	0.00114	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000352	0.00114	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000346	0.00112	CbGpPWpGaD
Vismodegib—ALB—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00033	0.00107	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000322	0.00105	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000321	0.00104	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000316	0.00103	CbGpPWpGaD
Vismodegib—ALB—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000315	0.00102	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000305	0.000989	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000289	0.00094	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000282	0.000917	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000281	0.000914	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000276	0.000895	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000268	0.00087	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000266	0.000864	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000258	0.000837	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000218	0.000709	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000218	0.000709	CbGpPWpGaD
Vismodegib—ALB—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000217	0.000705	CbGpPWpGaD
Vismodegib—ALB—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000217	0.000705	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000215	0.000698	CbGpPWpGaD
Vismodegib—ALB—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000214	0.000694	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—COMT—attention deficit hyperactivity disorder	0.000213	0.000693	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000212	0.000688	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.0002	0.000649	CbGpPWpGaD
Vismodegib—ALB—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000199	0.000645	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000195	0.000633	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000195	0.000633	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000192	0.000623	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00019	0.000618	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00019	0.000618	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000187	0.000608	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000178	0.000579	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000178	0.000577	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000178	0.000577	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000175	0.000568	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000175	0.000567	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000174	0.000565	CbGpPWpGaD
Vismodegib—ALB—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000174	0.000564	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00017	0.000552	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000166	0.00054	CbGpPWpGaD
Vismodegib—ALB—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000165	0.000537	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000163	0.000528	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000156	0.000506	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000152	0.000494	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000148	0.000482	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000145	0.00047	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000142	0.000462	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—EP300—attention deficit hyperactivity disorder	0.000139	0.000452	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000135	0.000439	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—COMT—attention deficit hyperactivity disorder	0.000132	0.00043	CbGpPWpGaD
Vismodegib—ALB—Metabolism—COMT—attention deficit hyperactivity disorder	0.000132	0.000427	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000131	0.000427	CbGpPWpGaD
Vismodegib—ALB—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000131	0.000424	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000127	0.000414	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000127	0.000412	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—COMT—attention deficit hyperactivity disorder	0.000118	0.000384	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000117	0.000381	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000117	0.000381	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000117	0.000381	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000115	0.000375	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000115	0.000374	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000114	0.000372	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000114	0.000369	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—COMT—attention deficit hyperactivity disorder	0.000108	0.00035	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000107	0.000348	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000107	0.000347	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000104	0.000337	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	9.37e-05	0.000304	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—EP300—attention deficit hyperactivity disorder	9.14e-05	0.000297	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	8.92e-05	0.00029	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	7.1e-05	0.000231	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	7.05e-05	0.000229	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—EP300—attention deficit hyperactivity disorder	5.67e-05	0.000184	CbGpPWpGaD
Vismodegib—ALB—Metabolism—EP300—attention deficit hyperactivity disorder	5.64e-05	0.000183	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—EP300—attention deficit hyperactivity disorder	5.07e-05	0.000165	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	4.94e-05	0.000161	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—EP300—attention deficit hyperactivity disorder	4.62e-05	0.00015	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	3.05e-05	9.89e-05	CbGpPWpGaD
